Medshield Says Healthcare Innovation Fails Without Affordability

In Short

• Medshield argues that better healthcare tools do not help if members cannot afford medical scheme cover.
• The scheme says healthcare inflation, hospital tariffs, and medicine prices keep rising while household budgets tighten.
• Medshield reports 10% net membership growth in 2026 to date, following 4.5% principal-member growth in 2025.
• It also reports a 53% solvency ratio.

What Happened

Medshield Medical Scheme published a thought leadership article that puts affordability at the centre of South Africa’s private healthcare debate. Medshield says healthcare innovation has limited value if members cannot keep paying monthly contributions.

The scheme’s principal officer, Kevin Aron, says many people only see the value of a medical scheme during major health shocks. He points to high-cost events like intensive care after a serious car accident, cancer treatment, emergency surgery, or premature birth care.

Medshield says the pressure is growing from both sides. Households face higher costs for essentials like food, electricity, and transport. At the same time, healthcare inflation is outpacing consumer inflation, and providers are charging higher hospital tariffs, plus rising medicine prices.

The article also highlights higher utilisation, meaning members are using more healthcare services. Medshield links this to lifestyle diseases, higher cancer prevalence, and longer lifespans.

On business performance, Medshield reports 10% net membership growth in 2026 to date, after 4.5% principal-member growth in 2025. It also reports a 53% solvency ratio, which is a financial buffer medical schemes must hold to pay future claims.

Why It Matters

For health funders and Health Tech builders, Medshield’s message is that adoption depends on price, not only product. If premiums rise faster than wages, membership stays flat and the market for private cover stops expanding.

Medshield also calls for more value-based reimbursement. That means paying providers based on health outcomes, not activities like consultations, procedures, or admissions. The bet is that prevention, earlier diagnosis, and coordinated care can reduce expensive complications, and slow long-term claims costs.

If medical schemes push harder toward outcomes-based contracts, it could shape where South African digital health spending goes next. Tools that prove cost savings and measurable outcomes are more likely to be funded than features that only add new layers of care.